option

Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia

TOKYO & HAYWARD, Calif.--(BUSINESS WIRE)--Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Arcus Biosciences, Inc. (NYSE:RCUS, “Arcus”) announced that Taiho exercised its…

2 weeks ago

IMG Expands iTravelInsured Choice with New Add-Ons and Specialized Plans

INDIANAPOLIS, Oct. 14, 2025 /PRNewswire/ -- IMG (International Medical Group) has announced new optional coverage add-ons to its most popular…

3 weeks ago

Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 10, 2025 16:41 ET  | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals,…

4 weeks ago

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…

2 months ago

IQ Option Joins Forces With United Autosports – Racing Partner Of McLaren Automotive

ST. JOHN'S, Antigua and Barbuda, Sept. 11, 2025 /PRNewswire/ -- IQ Option, an international online broker, has announced its new…

2 months ago

ASUS Brings 32GB RAM Option Within Everyones Reach with Exclusive Vivobook S16 Starting at C$799.99

KEY POINTS 32GB RAM for all: ASUS makes 32GB memory accessible to everyday users with Vivobook S16 laptops starting at…

2 months ago

Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes

September 03, 2025 21:47 ET  | Source: Mesoblast Limited NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…

2 months ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option

SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage…

3 months ago